XPHState Street SPDR S&P Pharmaceuticals ETF

Grow my money20y track recordRanked #550 of 2,960 in this goal

Seeks to provide investment results that correspond generally to the total return performance of an index derived from the pharmaceuticals segment.

By State Street Investment Management · Launched 2006

Annual Cost

0.35%

#1,706 of 5,562 · low cost

Fund Size

$353M

#1,836 of 5,562 · large

Return (1Y)Goal

+46.6%

Track Record

20 years

#326 of 5,562 · established

Performance

Total-return NAV · USD

Growth of $10,000

$15,150+51.5%

Total-return NAV, USD. Net of fund fees, before tax.

Classification

How Beacon categorizes this fund

Asset class

Equity

Region

North america

Cap

Large

Strategy

Index tracking

Sector

Health care

Focus

Pharmaceuticals

Index tracked

S&P Pharmaceuticals Select Industry Index

What it actually holds

By weight

Concentration

Top 10 holdings = 25.3% of fund✓ well diversified

State Street Global Advisors

6.7%

Axsome Therapeutics Inc

2.3%

Nuvation Bio Inc

2.1%

Xeris Biopharma Holdings Inc

2.1%

MBX Biosciences Inc

2.0%

EyePoint Inc

2.0%

Eli Lilly & Co

2.0%

Mind Medicine MindMed Inc

2.0%

Merck & Co Inc

2.0%

Supernus Pharmaceuticals Inc

2.0%

Asset allocation

Stocks

99.9%

Cash

0.1%

By sector

Healthcare

100.0%

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years

Volatility (1Y)

21.8%High

Year-on-year price swings

Max drawdown

-36.0%Severe

Worst peak-to-trough loss

Sharpe (3Y)

0.64Decent risk-adjusted returns

Sortino (3Y)

0.92Moderate downside risk

Where to buy

Listing

Exchange: NYSE Arca

Full fund details

Objective: Seeks to provide investment results that correspond generally to the total return performance of an index derived from the pharmaceuticals segment.
Strategy: Employs a sampling strategy to track the S&P Pharmaceuticals Select Industry Index, investing at least 80% of assets in its securities. The Fund may also invest in cash equivalents and may use futures contracts to manage cash flows and seek performance that corresponds to the Index.
Inception date: June 19, 2006
Fund family: State Street Investment Management